Skip to content

Dynamic Syndrome Evolution in Breast Cancer Patients During Chemotherapy: A Real-World Study

Dynamic Syndrome Evolution in Breast Cancer Patients During Chemotherapy: A Real-World Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500104203
Enrollment
Unknown
Registered
2025-06-12
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Observation group:None

Sponsors

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed diagnosis of breast cancer; 2.Tumor TNM stage I–III; 3.Aged 18–75 years; 4.First-time chemotherapy recipients; 5.Normal cognitive and comprehension abilities, with informed consent for this study.

Exclusion criteria

Exclusion criteria: 1.Patients with recurrence or distant metastasis; 2.Those receiving concurrent radiotherapy during chemotherapy; 3.Patients with other malignant tumors or severe heart, liver, or kidney diseases.

Design outcomes

Primary

MeasureTime frame
Traditional Chinese Medicine Symptom Scale;

Countries

China

Contacts

Public ContactHuang Yuhong

The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine

hyh101@126.com+86 130 1226 4996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026